Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuropsychological Impairment and Quality of Life in Neurofibromatosis Type 1

NCT01851135 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT01851135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01851135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuropsychological Impairment and Quality of Life in Neurofibromatosis Type 1
Lead sponsor
Nantes University Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2013
Completion date
April 30, 2016
Enrollment
286 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

neurofibromatosis type 1